This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Chinese Academy of Sciences. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Innovations of Tianyi Zheng in the Field of β-Coronaviruses
Introduction
Tianyi Zheng is a notable inventor based in Beijing, China. He has made significant contributions to the field of immunology, particularly in the development of antigens for β-coronaviruses. His work is crucial in the ongoing efforts to combat viral infections and enhance vaccine efficacy.
Latest Patents
Tianyi Zheng holds a patent titled "Antigens of β-coronaviruses, preparation methods and uses thereof." This patent describes various embodiments related to antigens of β-coronaviruses, including specific amino acid sequences arranged in distinct patterns. The antigen exhibits a single-chain dimer structure, which is stable and demonstrates excellent immunogenicity. Vaccines developed using this antigen have shown the ability to elicit high-titer neutralizing antibodies in mice, highlighting its potential for therapeutic applications.
Career Highlights
Tianyi Zheng is affiliated with the Chinese Academy of Sciences, where he conducts his research and development activities. His work has positioned him as a key figure in the field of virology and immunology, contributing to advancements that may lead to effective treatments and vaccines against coronaviruses.
Collaborations
Tianyi Zheng collaborates with esteemed colleagues such as Yan Li and Yi Shi. Their combined expertise fosters an environment of innovation and discovery, further enhancing the impact of their research.
Conclusion
Tianyi Zheng's contributions to the field of β-coronaviruses through his innovative patent and collaborative efforts underscore the importance of research in developing effective vaccines. His work is a testament to the ongoing fight against viral diseases and the potential for future breakthroughs in immunology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
